EndoClot Plus
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5201 Great America Pkwy Ste 526, Santa C...Phone Number
(408) 980-9125Website
www.endoclot.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About EndoClot Plus
EndoClot Plus, Inc. is a medical device company based in Santa Clara, California, specializing in innovative solutions for gastrointestinal bleeding control. They have developed the EndoClot Polysaccharide Hemostatic System (EndoClot PHS) in collaboration with endoscopists and biomaterial scientists. The company also manufactures a range of products including EndoClot Adhesive and EndoClot Submucosal Injection System through its subsidiary in China. EndoClot Plus aims to lead in creating new biomaterial therapeutic solutions for GI endoscopy professionals.Explore more
EndoClot Plus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EndoClot Plus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at EndoClot Plus
Check if EndoClot Plus has recently received funding, and reach out quickly before it becomes old news!
Check out if EndoClot Plus is spiking on competitors!
EndoClot Plus, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when EndoClot Plus launches new products
Funding: Get notified immidiatlly once EndoClot Plus has new funding data
Click to see if EndoClot Plus had a recent Job posting/layoffs
Earning: See what the market has to say on EndoClot Plus recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to EndoClot Plus
Compare insights from companies similar to EndoClot Plus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
EndoClot Plus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
EndoClot Plus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about EndoClot Plus.
EndoClot Plus Tech Stack
EndoClot Plus News & Media
Olympus Announces U.S. Distribution of EndoClot Polysaccharide Hemostatic Spray and EndoClot Submucosal Injection Agent
Based on EndoClot AMP Technology, Submucosal Injection Solution (SIS) and Polysaccharide Hemostatic Spray (PHS) Systems Assist with Submucosal Lift and Hemostasis During GI Procedures CENTER VALLEY, Pa., Sept. 12, 2022 /PRNewswire/ -- Olympus, a leading global medtech company providing...Olympus Announces Exclusive U.S. Distribution Agreement with EndoClot Plus, Inc.
Partnership will usher in new clinically differentiated solutions for the GI market while further strengthening Olympus' leadership in hemostasis, EMR and ESD CENTER VALLEY, Pa., April 4, 2022 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative...FDA Approves EndoClot® Hemostat to Manage GI Bleeding
SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc. receives FDA Clearance for it's Polysaccharide Hemostatic System to rapidly control upper and lower GI bleeding.EndoClot Plus, Inc. Announces FDA Clearance of GI Submucosal Lifting Product
SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc. (EPI), a privately held medical device company announced the FDA 510(k) clearance of EndoClot® Submucosal Injection Agent (EndoClot® SIA) manufactured by EndoClot Plus Co., Ltd. located in Suzhou, China. This product is expected to be commercially available in the United States beginning in May 2020 and later this year in several international markets. EndoClot® SIA is the first starch-derived submucosal injection system cleared in the U
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EndoClot Plus
Sign Up For FreeTo access detailed company insights
EndoClot Plus, Inc. is a medical device company based in Santa Clara, California, specializing in innovative solutions for gastrointestinal bleeding control. They have developed the EndoClot Polysaccharide Hemostatic System (EndoClot PHS) in collaboration with endoscopists and biomaterial scientists. The company also manufactures a range of product... Read More
